- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Jennifer Sullivan Explains the Importance of Continued Consumer Outreach
The work of consumer outreach and enrollment is never done, as Jennifer Sullivan, director of the Best Practices Institute at Enroll America, said that it’s important to partner with community leaders to continue engaging consumers well into the future.
The work of consumer outreach and enrollment is never done, as Jennifer Sullivan, director of the Best Practices Institute at Enroll America, said that it’s important to partner with community leaders to continue engaging consumers well into the future.
Transcript (slightly modified)
What are the main goals for Enroll America’s plan for outreach and enrollment?
So first and foremost, we will continue our cores, our bread and butter work of the Get Covered America Campaign, which is getting the word out to consumers, reaching as many individual consumers as possible in their communities to make sure they know what’s available to them.
But building on that, we want to connect to them to in-person help in their communities. We want to make it easier for those in-person assisters to reach out and to connect with consumers so that they can complete the enrollment process.
We also want to make sure that we are training, coaching and empowering local community leaders to carry this effort forward in the future. The work of outreach and enrollment will never be done, it’s something that needs to happen every year and we are working really hard to position our partners to continue this work well into the future.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Strategies for Improving Patient Access to Dermatology Care
March 22nd 2025Elizabeth Jones, MD, FAAD, highlights the persistent issue of insurance companies favoring expensive, newer medications over equally effective generics in dermatology, emphasizing the time-consuming prior authorization process and advocating for patient partnerships and systemic improvements.
Read More
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More
